☰

Haley L. Peters, Ph.D. - Publications

Affiliations: 
2012 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Oncology
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Sliker BH, Goetz BT, Peters HL, Poelaert BJ, Borgstahl GEO, Solheim JC. Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells. Cancer Biology & Therapy. 1-10. PMID 30810435 DOI: 10.1080/15384047.2019.1580414  0.768
2019 Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, et al. Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nature Communications. 10: 254. PMID 30651550 DOI: 10.1038/S41467-018-08109-6  0.503
2019 Mao W, Peters HL, Sutton MN, Orozco AF, Pang L, Yang H, Lu Z, Bast RC. The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts. Cancer. PMID 30620384 DOI: 10.1002/Cncr.31935  0.516
2018 Alatrash G, Perakis AA, Kerros C, Peters HL, Sukhumalchandra P, Zhang M, Jakher H, Zope M, Patenia RS, Sergeeva A, Yi S, Young KH, Philips AV, Herrmann AC, Garber HR, et al. Targeting the Leukemia Antigen PR1 with Immunotherapy for the treatment of Multiple Myeloma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29661776 DOI: 10.1158/1078-0432.Ccr-17-2626  0.37
2017 Kerros C, Tripathi SC, Zha D, Mehrens JM, Sergeeva A, Philips AV, Qiao N, Peters HL, Katayama H, Sukhumalchandra P, Ruisaard KE, Perakis AA, St John LS, Lu S, Mittendorf EA, et al. Neuropilin-1 mediates Neutrophil Elastase uptake and cross-presentation in breast cancer cells. The Journal of Biological Chemistry. PMID 28468826 DOI: 10.1074/Jbc.M116.773051  0.489
2017 Peters HL, Tripathi SC, Kerros C, Katayama H, Garber HR, St John LS, Federico L, Meraz IM, Roth JA, Sepesi B, Majidi M, Ruisaard K, Clise-Dwyer K, Roszik J, Gibbons DL, et al. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. Cancer Immunology Research. PMID 28254787 DOI: 10.1158/2326-6066.Cir-16-0141  0.502
2017 Kerros C, Tripathi SC, Zha D, Anna S, Peters HL, Katayama H, Sukhumalchandra P, Cox KR, Perakis AA, John LSS, Alatrash G, Mittendorf EA, Dwyer KC, Hanash SM, Molldrem JJ. Abstract 3984: Neuropilin-1 mediates neutrophil elastase uptake and antigen cross-presentation in breast cancer cells Cancer Research. 77: 3984-3984. DOI: 10.1158/1538-7445.Am2017-3984  0.557
2016 Chawla A, Alatrash G, Philips AV, Qiao N, Sukhumalchandra P, Kerros C, Diaconu I, Gall V, Neal S, Peters HL, Clise-Dwyer K, Molldrem JJ, Mittendorf EA. Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells. Cancer Immunology, Immunotherapy : Cii. PMID 27129972 DOI: 10.1007/S00262-016-1841-6  0.51
2016 Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez-Canales J, Liu H, Behrens C, Wistuba II, Ben-Jacob E, Levine H, Molldrem JJ, et al. Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929325 DOI: 10.1073/Pnas.1521812113  0.491
2016 Pandey P, Sliker B, Peters HL, Tuli A, Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, Coulter DW, Solheim JC. Amyloid precursor protein and amyloid precursor-like protein 2 in cancer. Oncotarget. PMID 26840089 DOI: 10.18632/Oncotarget.7103  0.707
2016 Perakis AA, Peters HL, Roszik J, Zhang M, Sergeeva A, Kerros C, Sukhumalchandra P, Philips AV, Khouri MR, Popat RU, St. John L, Talukder A, Hawke DH, Lizee G, Mittendorf EA, et al. Cross-Presentation Is a Source of Tumor Antigens for Multiple Myeloma Immunotherapy Blood. 128: 2104-2104. DOI: 10.1182/Blood.V128.22.2104.2104  0.412
2016 Tripathi SC, Peters HL, Ostrin EJ, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez J, Behrens C, Wistuba II, Jacob EB, Levine H, Molldrem JJ, et al. Abstract A060: Immunoproteasome deficiency is a feature of NSCLC with a mesenchymal phenotype and is associated with restricted antigen presentation and poor outcome in patients Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-A060  0.521
2016 Molldrem JJ, Sergeeva A, He H, Herrmann AC, Yang T, Kerros C, Peters H, Im JS, Parshottam S, Lu S, Ma Q, Dwyer KC, Mittendorf E, Alatrash G. Abstract IA17: T cell receptor-like antibody 8F4 targets leukemia and non-hematopoietic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Ia17  0.482
2016 Tripathi SC, Peters HL, Taguchi A, Katayama H, Wang H, Momin A, Jolly MK, Celiktas M, Rodriguez J, Liu H, Behrens C, Wistuba II, Levine H, Molldrem JJ, Hanash SM, et al. Loss of immunoproteasome driven by EMT is associated with immune evasion and poor prognosis in non-small cell lung cancer Journal of Thoracic Oncology. 11: S48-S49. DOI: 10.1016/J.Jtho.2015.12.080  0.432
2015 Pandey P, Rachagani S, Das S, Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters HL, Radhakrishnan P, McKenna NR, Giridharan SS, Haridas D, Kaur S, Hollingsworth MA, et al. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Oncotarget. 6: 2064-75. PMID 25576918 DOI: 10.18632/Oncotarget.2990  0.713
2013 Peters HL, Yan Y, Solheim JC. APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells. Oncoimmunology. 2: e26293. PMID 24353913 DOI: 10.4161/Onci.26293  0.671
2013 Peters HL, Yan Y, Nordgren TM, Cutucache CE, Joshi SS, Solheim JC. Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells. Cancer Biology & Therapy. 14: 752-60. PMID 23792571 DOI: 10.4161/Cbt.25183  0.67
2012 Peters HL, Tuli A, Wang X, Liu C, Pan Z, Ouellette MM, Hollingsworth MA, Macdonald RG, Solheim JC. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. International Journal of Oncology. 41: 1464-74. PMID 22797723 DOI: 10.3892/Ijo.2012.1553  0.723
2011 Peters HL, Tuli A, Sharma M, Naslavsky N, Caplan S, MacDonald RG, Solheim JC. Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2. Immunologic Research. 51: 39-44. PMID 21826533 DOI: 10.1007/S12026-011-8238-6  0.734
Show low-probability matches.